Lumos Pharma, Inc. ( LUMO) - Key Metrics
Stock symbol LUMO is outdated, potentially delisted? Maybe it is available on other exchange?
LUMO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | $0.09 | -$0.90 | -$0.60 | -$0.60 |
| 2024Q2 | $0.06 | -$0.93 | -$0.79 | -$0.79 |
| 2024Q1 | $0.02 | -$1.29 | -$1.59 | -$1.59 |
| 2023Q4 | $0.10 | -$1.17 | -$0.91 | -$2.54 |
| 2023Q3 | $0 | -$1.04 | -$0.98 | -$0.18 |
LUMO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | ? | -1.08 |
| 2024Q2 | ? | -0.61 |
| 2024Q1 | ? | -0.55 |
| 2023Q4 | ? | -0.68 |
| 2023Q3 | ? | -0.79 |
LUMO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2024Q3 | -15.53% | ? |
| 2024Q2 | -34.80% | ? |
| 2024Q1 | -56.02% | ? |
| 2023Q4 | -79.95% | ? |
| 2023Q3 | -5.47% | ? |
LUMO
Price: $4.34
52 week price:
Earnings Per Share: -4.28 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 22134
Market Capitalization: 37.5 million